Earnings summaries and quarterly performance for American Well.
Executive leadership at American Well.
Board of directors at American Well.
Research analysts who have asked questions during American Well earnings calls.
Jailendra Singh
Truist Securities
4 questions for AMWL
Also covers: ACCD, AGL, ASTH +16 more
CR
Charles Rhyee
TD Cowen
3 questions for AMWL
Also covers: BTSG, CAH, CI +18 more
CH
Craig Hettenbach
Morgan Stanley
3 questions for AMWL
Also covers: ACCD, ARDT, DH +10 more
David Larsen
BTIG
3 questions for AMWL
Also covers: ACCD, AGL, ASTH +19 more
Eric Percher
Nephron Research
3 questions for AMWL
Also covers: CAH, COR, CVS +5 more
SB
Stanislav Berenshteyn
Wells Fargo
3 questions for AMWL
Also covers: DOCS, GDRX, HCAT +3 more
Jessica Tassan
Piper Sandler
2 questions for AMWL
Also covers: ACCD, ALHC, CMAX +11 more
Kevin Caliendo
UBS
2 questions for AMWL
Also covers: AHCO, ALGN, CAH +15 more
Matthew Shea
Needham & Company
2 questions for AMWL
Also covers: AGL, CHGG, DCBO +5 more
Ryan MacDonald
Needham & Company
2 questions for AMWL
Also covers: ACCD, BNED, CHGG +17 more
Dolph Warburton
Nephron Research
1 question for AMWL
JS
Jack Senft
William Blair
1 question for AMWL
Also covers: HCSG, LFST, MD +3 more
JW
Jack Wallace
Guggenheim Partners
1 question for AMWL
Also covers: ACCD, PHR, VEEV +1 more
JP
John Park
Morgan Stanley
1 question for AMWL
Also covers: BJ, DOCS
LR
Lucas Romanski
BTIG
1 question for AMWL
Also covers: DRIO, ICLR, OWLT
SB
Stan Berenshteyn
Wells Fargo Securities
1 question for AMWL
Also covers: DOCS, GDRX, HQY +2 more
Recent press releases and 8-K filings for AMWL.
American Well Corporation Extends Key Agreements with Elevance Health
AMWL
New Projects/Investments
- American Well Corporation (AMWL) and its clinical partner, Online Care Group, PC, extended their Master Services Agreement and related provider agreements with Elevance Health, Inc. (formerly Anthem Inc.) for an additional three years, effective January 1, 2026, through January 1, 2029.
- Under these extended agreements, AMWL will continue to operate a white-labelled digital care delivery platform (LiveHealth Online®) for Elevance Health, receiving annual subscription fees and potential fees for professional services on a time and materials basis.
- The amendments also include updates to the contract term, Medicaid Exhibits, Required Information Security Controls (RISC) Exhibit, and add a provision pertaining to Artificial Intelligence (AI).
- Online Care Group, PC will continue to provide clinical professionals for digital care consultations to Elevance Health members and will receive a one-time provider access fee from Anthem by December 15, 2026.
Jan 2, 2026, 10:18 PM
AmWell Reports Q3 2025 Results, Updates Full-Year Guidance, and Reaffirms 2026 Cash Flow Break-Even Goal
AMWL
Earnings
Guidance Update
Layoffs
- AmWell reported Q3 2025 total revenue of $56.3 million, an 8% decrease year over year, though normalizing for the sale of APC, revenue would have increased by 1.3%. Subscription revenue grew 18% year over year to $30.9 million, comprising 55% of total revenue.
- The company significantly improved its profitability, reporting an Adjusted EBITDA loss of $12.7 million for Q3 2025, compared favorably to a loss of $31 million a year ago, primarily due to a 16% decrease in operating expenses and cost containment initiatives.
- AmWell updated its full-year 2025 revenue guidance to between $245 million and $248 million and narrowed its Adjusted EBITDA guidance to a loss between $45 million and $42 million. The company maintains its goal of achieving cash flow break-even from operations during 2026.
- The company ended Q3 2025 with approximately $201 million in cash and marketable securities and zero debt, with a cash burn of approximately $18 million for the quarter. Strategic efforts include focusing on its new platform, integrating AI, and pursuing further divestiture of non-core assets.
Nov 4, 2025, 10:00 PM
American Well Corporation Announces Q3 2025 Financial Results and Updates Guidance
AMWL
Earnings
Guidance Update
- American Well Corporation reported Total Revenue of $56.3 million for the third quarter ended September 30, 2025, with a net loss of ($31.9) million and Adjusted EBITDA of ($12.7) million.
- The company updated its 2025 revenue guidance to a range of $245 million to $248 million and narrowed its Adjusted EBITDA guidance to between ($45) million to ($42) million.
- For the fourth quarter of 2025, Amwell expects revenue in the range of $51 million to $54 million and Adjusted EBITDA in the range of ($15) million to ($12) million.
- Amwell also reiterated its objective to achieve positive cash flow from operations in 2026.
Nov 4, 2025, 9:13 PM
Quarterly earnings call transcripts for American Well.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more